Cello Health strengthens position in healthcare advisory market
ImmunoPrecise Antibodies is expanding its therapeutic offerings as a global full-service antibody provider
Cellmid directors show faith in company by participating in share placement
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.